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Background 
• Few data exist on secular trends of high 
blood pressure (HBP) detection and 
control in low and middle income 
countries, particularly in the African 
region. 
• This study examines trends of HBP over 
25 years based on 4 independent 
population surveys. 
• In the Seychelles, heath care is free to all 
inhabitants within a national health 
system, inclusive all HBP medications. 
• Previous studies have shown a transition 
from traditional to cardiometabolic 
cardiovascular risk factors in Seychelles.  
• Age adjusted cardiovascular disease 
mortality rates is high but decreasing 
over the last two decades. 
Methods 
• 4 independent population-based surveys 
were conducted in 1989, 1994, 2004 and 
2012 (Seychelles Heart Studies I, II, III 
and IV) in random samples of the 
population aged 25-64 (N~1200 and 
participation rate >70% in each survey). 
• Clinical measurements and self reported 
information on personal and lifestyle 
were gathered by trained health officers 
using same instruments in each survey. 
• BP was measured with an oscillometric 
device in 2013 (Omron M3) and a 
mercury device (Boso) in previous 
surveys, with cuff width adapted to arm 
circumference. The mean of the second 
and third BP readings is considered. 
• Data in this poster are presented for age 
45-64 in view of small proportions of 
persons treated for hypertension before 
age of 45, i.e.  
     6%/5% men/women in 1989 
     3%/4% men/women  in 1994  
     9%/11% men/women in 2004 
     9%/10% men/women in 2014 
 
 
  Men           Women       
1989 1994 2004 2013 1989 1994 2004 2013 
n 281 261 308 311 P   302 278 362 378 P 
BMI ≥25 27.0 43.7 57.0 60.6 * 64.3 71.9 80.4 83.2 * 
BMI ≥30 4.7 9.2 19.4 19.7 * 30.0 37.0 43.9 45.4 * 
Median MAP (mmHg) 107.0 110.5 106.3 104.9 * 106.2 106.9 102.5 100.1 * 
BP ≥140/90 60.0 67.9 57.0 52.4 * 53.3 53.4 43.9 40.7 * 
BP ≥140/90 or Rx (HBP/Rx) 61.4 69.0 64.5 61.8 ns 56.9 56.7 61.0 63.2 ns 
   % aware (of HBP) 37.7 34.8 64.7 65.3 * 52.8 57.1 80.4 75.0 * 
   % treated (of aware) 39.5 61.6 74.4 77.5 * 67.5 70.9 82.5 89.0 * 
   % controlled  (of Rx) 9.4 7.5 24.7 32.4 ns 18.7 14.6 41.1 55.0 * 
   % controled (of HBP/Rx) 0.9 1.1 7.7 10.1 *   3.8 3.4 16.7 23.2 * 
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Figure 1.  Proportions of awareness treatment and control of hypertension, age 45-64 
(percentages refer to the total numbers of men/women with HBP). 
Table 1. Proportions of awareness, treatment and control of HBP and distribution of 
overweight/obesity and  mean arterial pressure (MAP) by survey year, age 45-64.  
 
Conclusion 
• Awareness, treatment and control improved substantially during the past 24 years, but control should be 
further improved (only 17% of men and 36% of women are controlled in 2013). 
• Mean arterial BP decreased significantly despite a marked increase in mean BMI. 
• Diuretics, calcium channel blockers and ACEI/ARB are used in similar proportions. 
• Large proportions of persons treated for HBP take combinations of antihypertensive medications.  
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Figure 2.  Proportions of persons treated for HBP taking specific medications (left panel) 
and proportions taking combinations (right panel) 
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